Table 2.
SARS-CoV-2 vaccination status of the patients with multiple sclerosis (N = 193).
| SARS-CoV-2 vaccination1 | 1st vaccination | 2nd vaccination | 3rd vaccination2 |
|---|---|---|---|
| Vaccination received, n (%) | |||
| Yes | 163 (84.5) | 151 (78.2) | 25 (13.0) |
| No | 30 (15.5) | 42 (21,8) | 167 (87.0) |
| Type of vaccine received, n (%) | |||
| Tozinameran | 126 (77.3) | 128 (84.8) | 21 (84.0) |
| Elasomeran | 12 (7.4) | 13 (8.6) | 4 (16.0) |
| AZD1222 | 18 (11.0) | 9 (6.0) | 0 (0) |
| Ad26.COV2.S | 7 (4.3) | 1 (0.7) | 0 (0) |
N number, SARS-CoV-2 severe acute respiratory syndrome coronavirus 2.
1Vaccinations until the time point of data collection, which ended January 2022 (none of the patients had received more than three COVID-19 vaccinations).
2One case with missing data was not considered in the frequency tabulations.